| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 26 |
| 1 | PREDNISONE | 22 |
| 2 | CYCLOPHOSPHAMIDE | 17 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 5 | DOXORUBICIN | 17 |
| 6 | BENDAMUSTINE HCL | 11 |
| 7 | GEMCITABINE HYDROCHLORIDE | 7 |
| 8 | OXALIPLATIN | 7 |
| 9 | GEMCITABINE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIMIPRAMINE | 1 | 0.0009 |
| 1 | BENDAMUSTINE HCL | 11 | 0.0007 |
| 2 | ZANUBRUTINIB | 3 | 0.0007 |
| 3 | ECALLANTIDE | 1 | 0.0005 |
| 4 | BENDAMUSTINE HYDROCHLORIDE | 4 | 0.0005 |
| 5 | CHLORAMBUCIL | 1 | 0.0003 |
| 6 | CLADRIBINE | 2 | 0.0002 |
| 7 | RITUXIMAB-ABBS | 1 | 0.0002 |
| 8 | DOXORUBICIN | 17 | 0.0002 |
| 9 | POSACONAZOLE | 3 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 27 |
| 1 | Corticosteroid [EPC] | 25 |
| 2 | Alkylating Drug [EPC] | 18 |
| 3 | Platinum-based Drug [EPC] | 7 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 5 | Proton Pump Inhibitor [EPC] | 6 |
| 6 | Azole Antifungal [EPC] | 5 |
| 7 | Kinase Inhibitor [EPC] | 5 |
| 8 | Leukocyte Growth Factor [EPC] | 4 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Antimalarial [EPC] | 1 | 0.0001 |
| 2 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 27 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 18 | 0.0001 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 7 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 9 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |